Publicação

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents

Detalhes bibliográficos
Resumo:	Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
Autores principais:	Antimycobacterial Susceptibility Testing Group
Outros Autores:	Machado, D; Viveiros, M
Assunto:	Antimycobacterial Susceptibility Testing Breakpoints Antimicrobial resistance QR Microbiology RM Therapeutics. Pharmacology RA0421 Public health. Hygiene. Preventive Medicine Pulmonary and Respiratory Medicine Medical Laboratory Technology Infectious Diseases Microbiology (medical) Drug guides SDG 3 - Good Health and Well-being SDG 12 - Responsible Consumption and Production SDG 17 - Partnerships for the Goals
Ano:	2022
País:	Portugal
Tipo de documento:	editorial
Tipo de acesso:	acesso aberto
Instituição associada:	Universidade Nova de Lisboa
Idioma:	inglês
Origem:	Repositório Institucional da UNL

Descrição
Resumo:	Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6